Preferred Label : drug combinations;

MeSH definition : Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.;

MeSH synonym : combinations, drug;

Is substance : O;

MeSH annotation : IM for general only; NIM with specific drugs; differentiate from DRUG THERAPY, COMBINATION: drug combinations 2 or more drugs in a single dosage form; combination ther 2 or more drugs separately for a combined eff;;

Details


Main resources

You can consult :

Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture.

https://www.has-sante.fr/portail/jcms/c_2798157/fr/pergoveris
2017
false
false
false
France
French
evaluation of the transparency committee
pergoveris
follicle stimulating hormone
luteinizing hormone
drug combinations

---
https://www.has-sante.fr/portail/jcms/c_2666630/fr/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2017
false
false
false
France
French
scientific and technical information
medical
medical devices
drug therapy, combination
drug combinations
drug, nos
drug evaluation
device, nos
equipment and supplies
has patient
societies, medical
patients

---
http://ansm.sante.fr/S-informer/Points-d-information-Points-d-information/L-ANSM-suspend-a-titre-de-precaution-les-AMM-de-11-specialites-commercialisees-en-France-Point-d-Information
http://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/Rappel-de-lots-de-3-specialites-Perindopril-Indapamide-ZydusFrance-comprime-suite-a-la-suspension-des-AMM-decision-du-25-04-2017-prenant-effet-le-03-05-2017-Laboratoire-Zydus-France
http://ansm.sante.fr/S-informer/Informations-de-securite-Retraits-de-lots-et-de-produits/Rappels-de-lots-de-8-specialites-contenant-de-l-Hydroxyzine-suite-a-la-suspension-des-AMM-decision-du-25-04-2017-prenant-effet-le-03-05-2017-8-laboratoires-concernes
2017
false
false
false
France
French
pharmacovigilance note
Safety-Based drug withdrawals
france
hydroxyzine
administration, oral
indapamide, perindopril drug combination
perindopril and diuretics
hydroxyzine
indapamide
perindopril
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2751845/fr/codoliprane
2017
false
false
false
France
French
evaluation of the transparency committee
acetaminophen, codeine drug combination
codeine and paracetamol
administration, oral
acetaminophen
codeine
drug combinations

---
http://www.academie-medecine.fr/wp-content/uploads/2017/03/17.2.28-BOUVENOT-communiqué-site.pdf
2017
false
false
false
France
French
practice guideline
drug prescriptions
drug combinations
drug therapy, combination
treatment outcome
risk assessment
adult

---
http://www.has-sante.fr/portail/jcms/c_2743859/fr/paracetamol-codeine-sandoz
2017
false
false
false
France
French
evaluation of the transparency committee
paracetamol, combinations excl. psycholeptics
acetaminophen
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
drug combinations

---
http://circulaire.legifrance.gouv.fr/index.php?action=afficherCirculaire&hit=1&r=42484
http://circulaire.legifrance.gouv.fr/pdf/2017/08/cir_42484.pdf
2017
false
false
false
France
French
legislation
insurance, health, reimbursement
hepatitis C, chronic
elbasvir-grazoprevir drug combination
dasabuvir
legislation, drug
antiviral agents
ritonavir
Oral form ombitasvir + paritaprevir + ritonavir (product)
ombitasvir
paritaprevir
direct acting antivirals
daclatasvir
administration, oral
Simeprevir
sofosbuvir-velpatasvir drug combination
ledipasvir, sofosbuvir drug combination
Multidisciplinary care conference (procedure)
Interdisciplinary medical team conference (procedure)
ABT-333
ABT-267
ABT-450
BMS-790052
benzofurans
drug combinations
imidazoles
quinoxalines
Sofosbuvir
carbamates
Heterocyclic Compounds, 4 or More Rings
benzimidazoles
fluorenes
uridine monophosphate
uridine monophosphate
sulfonamides
uracil
uracil
anilides
macrocyclic compounds

---
http://www.minerva-ebm.be/FR/Article/2115
2017
false
false
false
Belgium
French
critical appraisal or critical reading
drug combinations
pulmonary disease, chronic obstructive
treatment outcome
administration, inhalation
glycopyrrolate
Formoterol Fumarate
bronchodilator agents
glucocorticoids
beclomethasone
disease exacerbation
pulmonary disease, chronic obstructive
forced expiratory volume
muscarinic antagonists
comparative effectiveness research
disease progression

---
http://www.has-sante.fr/portail/jcms/c_2730770/fr/malarone
2016
false
false
false
France
French
evaluation of the transparency committee
atovaquone
malarone
atovaquone, proguanil drug combination
proguanil
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2732140/fr/liptruzet
2016
false
false
false
France
French
evaluation of the transparency committee
liptruzet
azetidines
heptanoic acids
pyrroles
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa
http://www.has-sante.fr/portail/jcms/c_2724396/fr/epclusa-sofosbuvir/velpatasvir-association-fixe-d-antiviraux-a-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
insurance, health, reimbursement
treatment outcome
drug combinations
Sofosbuvir
Sofosbuvir
administration, oral
hepatitis C, chronic
antiviral agents
antiviral agents
velpatasvir
velpatasvir
hepatitis C, chronic
adult
other antivirals
guidelines for drug use
sofosbuvir-velpatasvir drug combination
sofosbuvir-velpatasvir drug combination
carbamates
Heterocyclic Compounds, 4 or More Rings
carbamates
Heterocyclic Compounds, 4 or More Rings
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2724390/fr/zepatier
http://www.has-sante.fr/portail/jcms/c_2724390/fr/zepatier-elbasvir/grazoprevir-association-fixe-d-antiviraux-a-action-directe
2016
false
false
false
France
French
evaluation of the transparency committee
elbasvir
elbasvir
drug combinations
antiviral agents
antiviral agents
hepatitis C, chronic
administration, oral
grazoprevir
grazoprevir
benzofurans
benzofurans
imidazoles
imidazoles
quinoxalines
quinoxalines
treatment outcome
adult
hepatitis C, chronic
insurance, health, reimbursement
elbasvir and grazoprevir
guidelines for drug use
elbasvir-grazoprevir drug combination
elbasvir-grazoprevir drug combination
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676753/fr/algisedal
2016
false
France
French
child
adolescent
pregnancy
pain
treatment outcome
moderate pain
severe pain
breast feeding
CYP2D6 ultrarapid metabolizer status
codeine and paracetamol
tablets
administration, oral
drug combinations
acetaminophen, codeine drug combination
codeine
acetaminophen
analgesics, non-narcotic
analgesics, opioid
adult
insurance, health, reimbursement
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2666630/en/contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
http://www.has-sante.fr/portail/jcms/c_2681820/en/guide-pour-les-associations-de-patients-et-d-usagers-contribution-aux-evaluations-des-produits-de-sante
http://www.has-sante.fr/portail/jcms/c_2720917/en/methode-d-elaboration-par-la-has-contribution-des-associations-de-patients-et-d-usagers-aux-evaluations-de-medicaments-et-dispositifs-medicaux
2016
false
false
false
France
French
handbooks
drug therapy, combination
drug combinations
patients
societies, medical
drug evaluation
device, nos
medical devices
equipment and supplies
has patient
medical
drug, nos

---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00329
2016
false
false
false
Canada
French
drug information
sofosbuvir-velpatasvir drug combination
Sofosbuvir
carbamates
drug combinations
Heterocyclic Compounds, 4 or More Rings

---
http://www.has-sante.fr/portail/jcms/c_2676678/fr/paracetamol-codeine-cristers
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
acetaminophen
codeine
codeine
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676684/fr/paracetamol-codeine-mylan
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
codeine
codeine
acetaminophen, codeine drug combination
acetaminophen
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676690/fr/paracetamol-codeine-eg
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
acetaminophen
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676699/fr/paracetamol-codeine-teva
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
acetaminophen
codeine
codeine
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2676717/fr/paracetamol-codeine-biogaran-ref
2016
false
false
false
France
French
evaluation of the transparency committee
acetaminophen
acetaminophen, codeine drug combination
codeine
codeine
acetaminophen
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004025/human_med_001948.jsp&mid=WC0b01ac058001d124
2016
false
Great Britain (UK)
French
English
syndication feed
drugs, generic
Lopinavir+ritonavir (product)
human immunodeficiency virus i infection
Lopinavir 100mg/ritonavir 25mg tablet (product)
Lopinavir+ritonavir 200mg/50mg tablet (product)
lopinavir
lopinavir
lopinavir-ritonavir drug combination
lopinavir-ritonavir drug combination
acquired immunodeficiency syndrome
adult
child
drug interactions
hiv protease inhibitors
anti-hiv agents
treatment outcome
drug evaluation
drug combinations
ritonavir
administration, oral
hiv infections
adolescent
anti-hiv agents
hiv protease inhibitors
drug therapy, combination
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
HIV-1
ritonavir
package leaflet
summary of product characteristics
drug evaluation
lopinavir and ritonavir
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2612472/fr/rifater
http://www.has-sante.fr/portail/jcms/c_461162/fr/rifater
http://www.has-sante.fr/portail/jcms/c_399103/fr/rifater-comprime-enrobe-boite-de-60
2016
false
true
false
false
France
French
evaluation of the transparency committee
administration, oral
insurance, health, reimbursement
treatment outcome
isoniazid, pyrazinamide, rifampin drug combination
drug combinations
rifampicin, pyrazinamide and isoniazid
tuberculosis
tuberculosis, pulmonary
antitubercular agents
isoniazid
pyrazinamide
rifampin
antibiotic therapy
drug combinations

---
https://www.revmed.ch/RMS/2016/RMS-N-527/Combinaison-gliptine-gliflozine-dans-le-traitement-du-diabete-de-type-2
2016
false
false
false
Switzerland
French
journal article
diabetes mellitus, type 2
drug combinations
hypoglycemic agents
dipeptidyl-peptidase iv inhibitors
SGLT2 Inhibitor
treatment outcome
saxagliptin and dapagliflozin
dapagliflozin
saxagliptin
Linagliptin
linagliptin and empagliflozin
empagliflozin
Empagliflozin + linagliptin (product)
administration, oral
Sodium-Glucose transporter 2
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
dipeptides
adamantane
adamantane
benzhydryl compounds
glucosides

---
http://www.has-sante.fr/portail/jcms/c_2630429/fr/quelle-place-pour-les-associations-fixes-corticoide-/-beta-2-mimetique-de-longue-duree-d-action-dans-le-traitement-de-la-bronchopneumopathie-chronique-obstructive
2016
false
false
false
France
French
guidelines for drug use
pulmonary disease, chronic obstructive
drug combinations
formoterol and beclometason
formoterol and budesonide
Budesonide, Formoterol Fumarate Drug Combination
administration, inhalation
Formoterol Fumarate
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
bronchodilator agents
salmeterol and fluticasone
vilanterol and fluticasone furoate
Fluticasone
vilanterol
beclomethasone
glucocorticoids
adrenergic beta-2 receptor agonists
treatment outcome
benzyl alcohols
chlorobenzenes

---
http://www.has-sante.fr/portail/jcms/c_2628635/fr/tienam
2016
true
France
French
antibiotic therapy
complicated skin and soft tissue infection
drug combinations
infusions, intravenous
cilastatin sodium
cilastatin
imipenem
cilastatin, imipenem drug combination
imipenem and enzyme inhibitor
anti-bacterial agents
protease inhibitors
adult
adolescent
child
intraabdominal infections
pneumonia, bacterial
cross infection
pregnancy complications, infectious
soft tissue infections
skin diseases, infectious
urinary tract infections
bacterial infections
bacterial infections
drug combinations
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/jcms/c_2617874/fr/targinact
2016
false
France
French
evaluation of the transparency committee
Naloxone Hydrochloride
Oxycodone Hydrochloride
restless legs syndrome
oxycodone naloxone combination
drug combinations
Delayed-Action preparations
oxycodone
naloxone
administration, oral
narcotics
insurance, health, reimbursement
adult
treatment outcome
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2656337/fr/orkambi
http://www.has-sante.fr/portail/jcms/c_2656337/fr/orkambi-lumacaftor-/-ivacaftor-correcteur-et-potentialisateur-du-gene-cftr
2016
false
false
false
France
French
drug combinations
aminophenols
aminopyridines
aminopyridines
aminophenols
quinolones
quinolones
benzodioxoles
benzodioxoles
adolescent
adult
CFTR gene.p.F508 del
cystic fibrosis transmembrane conductance regulator
cystic fibrosis transmembrane conductance regulator delta F508
cystic fibrosis
ivacaftor
ivacaftor
treatment outcome
ivacaftor and lumacaftor
lumacaftor, ivacaftor drug combination
lumacaftor, ivacaftor drug combination
evaluation of the transparency committee
insurance, health, reimbursement
forced expiratory volume
guidelines for drug use
orphan drug production
lumacaftor
lumacaftor
cystic fibrosis transmembrane conductance regulator
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_400288/fr/auricularum
http://www.has-sante.fr/portail/jcms/c_2585417/fr/auricularum-oxytetracycline-polymyxine-b-dexamethasone-nystatine-association-fixe-d-antibiotiques-antimycosique-corticoide
2015
false
true
false
false
France
French
evaluation of the transparency committee
instillation, drug
dexamethasone and antiinfectives
auricularum
otitis externa
perioperative period
chronic disease
otitis
ear
perioperative care
treatment outcome
insurance, health, reimbursement
anti-inflammatory agents
glucocorticoids
anti-bacterial agents
antifungal agents
administration, topical
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
antibiotic therapy
guidelines for drug use
nystatin
oxytetracycline
polymyxin B
dexamethasone
dexamethasone
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003954/human_med_001935.jsp&mid=WC0b01ac058001d124
2015
false
false
false
Great Britain (UK)
French
English
summary of product characteristics
package leaflet
drug combinations
aminophenols
aminopyridines
aminopyridines
aminophenols
quinolones
quinolones
benzodioxoles
benzodioxoles
continuity of patient care
adolescent
adult
CFTR gene.p.F508 del
cystic fibrosis transmembrane conductance regulator
cystic fibrosis transmembrane conductance regulator delta F508
cystic fibrosis
ivacaftor
ivacaftor
drug evaluation
syndication feed
drug approval
europe
treatment outcome
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
product surveillance, postmarketing
ivacaftor and lumacaftor
lumacaftor, ivacaftor drug combination
lumacaftor, ivacaftor drug combination
lumacaftor
lumacaftor
cystic fibrosis transmembrane conductance regulator
drug combinations
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002611/human_med_001934.jsp&mid=WC0b01ac058001d124
2015
false
Great Britain (UK)
English
French
drug approval
europe
summary of product characteristics
package leaflet
drug evaluation
syndication feed
carbidopa
levodopa
adult
carbidopa, levodopa drug combination
Aromatic Amino Acid Decarboxylase Inhibitors
Aromatic Amino Acid Decarboxylase Inhibitors
treatment outcome
carbidopa
carbidopa, levodopa drug combination
levodopa
administration, oral
drug combinations
levodopa and decarboxylase inhibitor
dopa decarboxylase
antiparkinson agents
dopamine agents
insurance, health, reimbursement
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2559109/fr/kivexa
2015
false
false
false
France
French
evaluation of the transparency committee
Kivexa
dideoxynucleosides
lamivudine
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2022230/fr/prinzide
http://www.has-sante.fr/portail/jcms/c_854100/prinzide
2015
false
France
French
hydrochlorothiazide, lisinopril drug combination
lisinopril and diuretics
hypertension
hydrochlorothiazide
lisinopril
antihypertensive agents
drug combinations
diuretics
angiotensin-converting enzyme inhibitors
administration, oral
insurance, health, reimbursement
sodium chloride symporter inhibitors
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_2037318/fr/spifen
2015
true
France
French
-
adult
child
treatment outcome
antimigraine preparations
ibuprofen
administration, oral
-
-
other antimigraine preparations
ibuprofen
pain
migraine disorders
insurance, health, reimbursement
fever
ibuprofen arginine
arginine
drug combinations
evaluation of the transparency committee
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/003687/human_med_001845.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500179027
2015
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug approval
europe
naltrexone
naltrexone
bupropion
bupropion
anti-obesity agents
anti-obesity agents
product surveillance, postmarketing
adult
overweight
obesity
overweight
body mass index
administration, oral
Delayed-Action preparations
appetite
energy metabolism
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
bupropion hydrochloride, naltrexone hydrochoride drug combination
bupropion hydrochloride, naltrexone hydrochoride drug combination
bupropion and naltrexone
Oral form bupropion + naltrexone (product)
drug combinations
drug combinations
naltrexone
bupropion

---
http://www.has-sante.fr/portail/jcms/c_2031539/fr/dualkopt
2015
false
false
false
France
French
evaluation of the transparency committee
timolol, combinations
dorzolamide hydrochloride-timolol maleate combination
dorzolamide hydrochloride-timolol maleate combination
dorzolamide-timolol combination
dorzolamide-timolol combination
dorzolamide
dorzolamide
ophthalmic solutions
administration, ophthalmic
adrenergic beta-antagonists
adrenergic beta-antagonists
carbonic anhydrase inhibitors
carbonic anhydrase inhibitors
treatment outcome
insurance, health, reimbursement
ocular hypertension
exfoliation syndrome
glaucoma, open-angle
drug combinations
sulfonamides
thiophenes
timolol
drug combinations
sulfonamides
thiophenes
timolol

---
http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro
http://www.has-sante.fr/portail/jcms/c_2017120/fr/velphoro-oxyhydroxyde-sucro-ferrique-hypophosphoremiant
2015
false
false
false
France
French
evaluation of the transparency committee
sucroferric oxyhydroxide
administration, oral
hyperphosphatemia
renal insufficiency, chronic
renal dialysis
peritoneal dialysis
treatment outcome
insurance, health, reimbursement
guidelines for drug use
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
http://www.has-sante.fr/portail/jcms/c_2040751/fr/daivobet
2015
true
France
French
scalp psoriasis
betamethasone dipropionate, calcipotriol drug combination
administration, topical
drug combinations
psoriasis
calcipotriol, combinations
calcipotriene
betamethasone
calcitriol
betamethasone-17,21-dipropionate
insurance, health, reimbursement
scalp dermatoses
administration, cutaneous
adult
treatment outcome
gels
evaluation of the transparency committee
drug combinations

---
http://ansm.sante.fr/S-informer/Informations-de-securite-Lettres-aux-professionnels-de-sante/Diane-35-et-ses-generiques-mise-a-disposition-de-documents-pour-minimiser-le-risque-thromboembolique-Lettre-aux-professionnels-de-sante
http://ansm.sante.fr/content/download/71243/907139/version/1/file/Document_Aide_Prescription_Diane_35.pdf
http://ansm.sante.fr/content/download/71241/907125/version/1/file/Carte_patiente_type_Diane35.pdf
2014
false
false
false
France
French
guidelines for drug use
thromboembolism
drug prescriptions
drugs, generic
cyproterone acetate, ethinyl estradiol drug combination
risk factors
cyproterone acetate, ethinyl estradiol drug combination
thromboembolism
risk management
thromboembolism
signs and symptoms
patient education handout
acne vulgaris
product surveillance, postmarketing
hirsutism
ethinyl estradiol
cyproterone acetate
drug combinations
ethinyl estradiol
cyproterone acetate
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1774141/fr/omacor
2014
false
France
French
drug combinations
docosahexaenoic acids
Omacor
eicosapentaenoic acid
omega-3-triglycerides incl. esters and acids
insurance, health, reimbursement
hypertriglyceridemia
adult
myocardial infarction
treatment outcome
drug therapy, combination
alpha-Tocopherol
evaluation of the transparency committee
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002705/human_med_001795.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500169179
2014
false
false
false
Great Britain (UK)
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
sucroferric oxyhydroxide
drug approval
europe
administration, oral
Chewable Tablet Dosage Form
hyperphosphatemia
adult
renal insufficiency
drug therapy, combination
bone diseases
peritoneal dialysis
renal dialysis
chelating agents
chelating agents
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
sucroferric oxyhydroxide
sucroferric oxyhydroxide
drug combinations
ferric compounds
sucrose
drug combinations
ferric compounds
sucrose

---
http://www.has-sante.fr/portail/jcms/c_1753126/fr/divina-duova
2014
false
France
French
postmenopause
estrogens
divina
drug combinations
administration, oral
medroxyprogesterone and estrogen
medroxyprogesterone and estrogen
medroxyprogesterone acetate
estradiol valerate
estradiol
hormone replacement therapy
insurance, health, reimbursement
estrogens
progesterone congeners
osteoporosis, postmenopausal
osteoporotic fractures
evaluation of the transparency committee
drug combinations
estradiol
medroxyprogesterone

---
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40839a-fra.php
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2014/40841a-fra.php
2014
false
false
false
Canada
French
NuvaRing
etonogestrel
administration, intravaginal
contraceptive devices, female
risk factors
thrombosis
vaginal ring with progestogen and estrogen
pharmacovigilance note
drug combinations
ethinyl estradiol
desogestrel
desogestrel

---
http://www.has-sante.fr/portail/jcms/c_1750090/fr/coveram
http://www.has-sante.fr/portail/jcms/c_840942/coveram
2014
false
France
French
amlodipine
Amlodipine Besylate
arginine
perindopril
amlodipine
arginine
perindopril
amlodipine, perindopril drug combination
antihypertensive agents
amlodipine, perindopril drug combination
amlodipine
drug combinations
perindopril and amlodipine
perindopril
administration, oral
insurance, health, reimbursement
treatment outcome
hypertension
coronary artery disease
calcium channel blockers
angiotensin-converting enzyme inhibitors
Amlodipine Besylate
evaluation of the transparency committee
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1743051/fr/xamiol
http://www.has-sante.fr/portail/jcms/c_778871/xamiol
2014
false
false
false
France
French
evaluation of the transparency committee
calcipotriol, combinations
administration, topical
insurance, health, reimbursement
treatment outcome
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
psoriasis
scalp dermatoses
adult
meta-analysis as topic
glucocorticoids
adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
betamethasone
betamethasone
calcitriol
calcitriol
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1739166/fr/pediazole
http://www.has-sante.fr/portail/jcms/c_399647/fr/pediazole-granule-pour-sirop-flacon-de-200-ml
2014
false
false
false
France
French
evaluation of the transparency committee
acetyl sulfisoxazole
drug combinations
administration, oral
insurance, health, reimbursement
MK 0641
erythromycin ethylsuccinate
anti-bacterial agents
sulfonamides, combinations with other antibacterials (excl. trimethoprim)
treatment outcome
otitis media
acute disease
haemophilus infections
haemophilus influenzae
child
otitis media acute
antibiotic therapy
acetyl sulfisoxazole
erythromycin
sulfisoxazole
drug combinations
sulfisoxazole

---
http://www.cochrane.org/fr/CD005052
2014
false
false
false
France
drugs, chinese herbal
heart failure
treatment outcome
drugs, chinese herbal
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
fructus schizandrae, radix ginseng, radix ophiopogonis drug combination
drug combinations
medicine, chinese traditional
phytotherapy
meta-analysis
french abstract
drug combinations
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1759931/fr/contraception-estroprogestative-transdermique-ou-vaginale-dispensation-en-officine
2013
false
true
false
France
French
professional role
pharmacists
pharmacy
contraception
adult
adolescent
administration, intravaginal
administration, cutaneous
contraceptive agents, female
transdermal patch
Ortho Evra
NuvaRing
contraceptive devices, female
vaginal ring with progestogen and estrogen
norelgestromin and ethinylestradiol
drug interactions
counseling
drug prescriptions
guideline
ethinyl estradiol
norgestrel
drug combinations
desogestrel

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002499/human_med_001608.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500133559
2013
false
Great Britain (UK)
English
French
insulin degludec and insulin aspart
insulin degludec, insulin aspart drug combination
insulin degludec, insulin aspart drug combination
insulin aspart
drug combinations
drug approval
europe
treatment outcome
insulin, long-acting
insulin, long-acting
hypoglycemic agents
hypoglycemic agents
injections, subcutaneous
diabetes mellitus, type 1
diabetes mellitus, type 2
summary of product characteristics
package leaflet
drug evaluation
syndication feed
recombinant proteins
adult
aged
drug interactions
pregnancy
breast feeding
fertility
randomized controlled trials as topic
hemoglobin A, glycosylated
drug combinations
drug combinations
insulin aspart
insulin degludec
insulin degludec

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000964/human_med_001014.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124
http://www.ema.europa.eu/ema/generateFeed/medicines/WC500019723
2012
Great Britain (UK)
French
English
syndication feed
antihypertensive agents
amides
diuretics
fumarates
hydrochlorothiazide
drug combinations
hydrochlorothiazide
amides
fumarates
tablets
administration, oral
adult
drug approval
aliskiren
aliskiren
breast feeding
diuretics
renin
drug evaluation, preclinical
treatment outcome
drug labeling
aged
drug interactions
pregnancy
aliskiren and hydrochlorothiazide
amides
fumarates
package leaflet
drug evaluation
summary of product characteristics

---
http://www.has-sante.fr/portail/jcms/c_1231626/ganfort
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-03/ganfort_29022012_avis_ct10497.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_460037
2012
false
France
French
evaluation of the transparency committee
Bimatoprost
ganfort
ophthalmic solutions
drug combinations
amides
cloprostenol
antihypertensive agents
timolol maleate
adrenergic beta-antagonists
timolol
insurance, health, reimbursement
glaucoma, open-angle
ocular hypertension
timolol, combinations
administration, ophthalmic
drug combinations

---
http://www.has-sante.fr/portail/jcms/c_1329540/teysuno
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/teysuno__03102012_avis_ct12048.pdf
2012
false
France
French
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
drug combinations
administration, oral
gimeracil
gimeracil
adult
stomach neoplasms
antineoplastic combined chemotherapy protocols
tegafur
tegafur
oxonic acid
oxonic acid
tegafur, combinations
antineoplastic agents
antineoplastic agents
insurance, health, reimbursement
evaluation of the transparency committee
treatment outcome
randomized controlled trials as topic
survival analysis
pyridines
pyridines
drug combinations
drug combinations

---
https://www.revmed.ch/RMS/2012/RMS-360/Sommes-nous-prets-a-prescrire-une-polypill-a-nos-patients
2012
Switzerland
French
journal article
cardiovascular diseases
secondary prevention
medication adherence
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000668/human_med_000804.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124
2012
false
Great Britain (UK)
French
English
syndication feed
ganfort
ganfort
Bimatoprost
Bimatoprost
glaucoma, open-angle
ocular hypertension
timolol
timolol
adrenergic beta-antagonists
adrenergic beta-antagonists
antihypertensive agents
antihypertensive agents
treatment outcome
drug evaluation
drug combinations
drug labeling
drug approval
ophthalmic solutions
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
timolol, combinations
timolol maleate
timolol maleate
administration, ophthalmic
package leaflet
drug evaluation
summary of product characteristics
amides
cloprostenol
cloprostenol
drug combinations
amides
cloprostenol
drug combinations

---
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001242/human_med_001422.jsp&mid=WC0b01ac058001d125&murl=menus/medicines/medicines.jsp
2012
false
Great Britain (UK)
French
English
tegafur-gimeracil-oteracil
tegafur-gimeracil-oteracil
syndication feed
tegafur
gimeracil
oxonic acid
drug combinations
gimeracil
tegafur
oxonic acid
drug approval
treatment outcome
pyridines
pyridines
tegafur, combinations
administration, oral
adult
antineoplastic agents
antineoplastic agents
stomach neoplasms
antineoplastic combined chemotherapy protocols
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
pyridines
summary of product characteristics
package leaflet
drug evaluation
drug combinations
drug combinations

---
http://www.minerva-ebm.be/fr/article/233
2011
false
true
false
minerva-ebm.be
Belgium
child
child, preschool
respiratory tract infections
camphor, cedar leaf oil, eucalyptus oil, menthol, myristica oil, terebinth oil, thymol drug combination
critical appraisal or critical reading
ointments
cough
plant extracts
terpenes
drug combinations

---
http://www.minerva-ebm.be/fr/article/356
2009
minerva-ebm.be
Belgium
French
atrial fibrillation
aspirin
atrial fibrillation
drug combinations
critical appraisal or critical reading

---
http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:328:0042:0048:FR:PDF
2008
legislation
drug utilization
drug therapy, combination
plant preparations
drug combinations

---
http://lecrat.fr/spip.php?page=article&id_article=817
2008
France
French
adrenergic beta-antagonists
timolol
pilocarpine
pregnancy
breast feeding
drug combinations
antihypertensive agents
miotics
timolol, combinations
drug information

---
http://www.has-sante.fr/portail/jcms/c_719595/kivexa
2008
France
French
Kivexa
abacavir
abacavir, lamivudine drug combination
HLA-B*57:01 antigen
reverse transcriptase inhibitors
lamivudine
dideoxynucleosides
drug combinations
administration, oral
tablets
genetic testing
anti-hiv agents
HLA-B antigens
hiv infections
drug therapy, combination
adult
adolescent
drug hypersensitivity
lamivudine and abacavir
abacavir sulfate
dideoxynucleosides
HLA-B antigens
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_487033
2007
France
French
drug combinations
erysimum
plant extracts
antitussive agents
pharmaceutical solutions
codeine
opium alkaloids and derivatives
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_603111
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-4879_intetrix_.pdf
2007
France
French
drug combinations
intetrix
tilbroquinol
oxyquinoline
administration, oral
insurance, health, reimbursement
tilbroquinol
5-methyl-8-hydroxyquinoline
adult
dysentery, amebic
evaluation of the transparency committee

---
http://www.cadth.ca/media/pdf/385_steroids_tr_fr.pdf
http://www.cadth.ca/media/pdf/385_steroids_appendices_fr.pdf
https://www.cadth.ca/fr/association-dun-ss2-agoniste-action-prolongee-baap-et-dun-corticosteroide-en-comparaison-un-baap
2007
true
Canada
French
adrenocortical steroid therapy
corticosteroid therapy
drug combinations
adrenal cortex hormones
pulmonary disease, chronic obstructive
drug evaluation

---
http://www.has-sante.fr/portail/display.jsp?id=c_400861
2006
France
French
drug combinations
erysimum
plant extracts
antitussive agents
capsules
codeine
opium alkaloids and derivatives
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400184
2005
France
French
drug combinations
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
sodium chloride symporter inhibitors
antihypertensive agents
quinapril
quinapril and diuretics
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_400267
2005
France
French
drug combinations
antihypertensive agents
sodium chloride symporter inhibitors
diuretics
hydrochlorothiazide
tablets
tetrahydroisoquinolines
angiotensin-converting enzyme inhibitors
quinapril
quinapril and diuretics
evaluation of the transparency committee

---
http://www.fmoq.org/Lists/FMOQDocumentLibrary/fr/Le%20M%C3%A9decin%20du%20Qu%C3%A9bec/Archives/2000%20-%202009/101-103HardyMC0502.pdf
2002
false
true
false
Canada
French
drug combinations
journal article
clopidogrel
aspirin
acute coronary syndrome

---
http://www.has-sante.fr/portail/display.jsp?id=c_399703
2002
France
French
drug combinations
artemisinins
antimalarials
ethanolamines
fluorenes
lumefantrine
artemether
artemether-lumefantrine combination
artemether and lumefantrine
evaluation of the transparency committee

---
http://whqlibdoc.who.int/hq/2001/WHO_CDS_RBM_2001.35_fre.pdf
2001
Switzerland
French
malaria
antimalarials
drug combinations
africa
practice guideline

---
E-mail
17/11/2017


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.